Rocket One Inc. is a technology company focused on developing and commercializing infrastructure for the orbital economy and advanced computing markets. Headquartered in Hoboken, New Jersey, the company centers its activities on next-generation nanomagnetic AI chip architectures designed for ultra-low-power, radiation-tolerant computing in space and defense environments. These chips target use cases such as low-Earth orbit satellites, deep-space platforms, and mission-critical defense systems where reliability, energy efficiency, and resilience to radiation are essential. Rocket One holds exclusive rights to nanomagnetic matrix-multiplier hardware accelerators for machine learning and AI workloads, along with related magnetic memory technologies aimed at radiation-tolerant computing. In addition, the company is positioned to pursue opportunities in nano-launch systems and nanosatellite deployment, linking its semiconductor capabilities with broader space-infrastructure applications. Rocket One also maintains a biotechnology pipeline, including programs in oncology side-effect management, mast-cell cancers, neuroinflammatory diseases, dermatology, respiratory conditions, and metabolic disorders, which are advanced through a wholly owned subsidiary. This combination of space-focused AI hardware and specialized biotech assets gives Rocket One a distinct multi-sector presence in today’s public markets.